Treatment of diabetes with 'educated' immune cells

Image
ANI Washington D.C. [USA]
Last Updated : Jul 07 2017 | 5:02 PM IST

New research has revealed that a treatment called Stem Cell Educator therapy is safe and effective for treating type 1 and type 2 diabetes.

In the therapy, the patient's immune cells cultures with cord blood stem cells and returns only the "educated" immune cells to the patient's circulation.

The strategy is believed to provide benefits because abnormalities in multiple types of immune cells contribute to the autoimmunity in type1diabetes and the insulin resistance in type 2 diabetes.

Dr YongZhao, lead author of the study said, "Current mechanistic studies demonstrated that platelets and their released mitochondria may contribute to the long-lasting clinical improvement of islet beta cell function in type 1 and 2 diabetic patients after Stem Cell Educator therapy."

He added, "This therapy can also be applied to treat other autoimmune and inflammation-related diseases."

.

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Jul 07 2017 | 5:02 PM IST

Next Story